ABSTRACT Introduction: Calcium channel blockers (CCBs) comprise a heterogeneous
group of medications that reduce calcium influx and attenuate cellular hyperactivity …

Background Depressive symptoms are common in patients with coronary artery disease
(CAD) and are associated with an unfavourable outcome. Establishing prognostic patient …

Background: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor
blockers (ARBs), commonly used antihypertensive drugs, may have a protective effect …

Background Bipolar disorder (BD) is associated with excess and premature cardiovascular
mortality. Elevated blood pressure (BP) is a leading contributor to cardiovascular risk …

Incident depression has been reported to be associated with poor prognosis in patients with
cardiovascular disease (CVD), which might be associated with beta-blocker therapy …

Abstract Purpose of Review Hypertension is recognised as the biggest contributor to the
global burden of disease, but it is controlled in less than a fifth of patients worldwide, despite …

Purpose Development of new thymoleptic medications has primarily centered on
anticonvulsants and antipsychotic drugs. Based on our studies of intracellular calcium ion …

There is no approved drug capable of halting the progression of the most prevalent
neurodegenerative disorders, namely Alzheimer's disease (AD) and Parkinson's disease …

BACKGROUND Poor mental health status is more prevalent in women and may be related
to poor hypertension outcomes and increased hospital inpatient visits. This study aims to …

Background: Since few studies have investigated the risk of high blood pressure associated
with objective insomnia and self-reported insomnia complaints in major depression, the aim …